Theraclion SA
Theraclion SA provides therapeutic ultrasound equipment. It offers SONOVEIN, a robotic solution for the non-invasive echotherapy treatment of varicose veins; ECHOPULSE, a robotic and non-invasive solution for the echotherapy treatment of thyroid nodules and breast fibroadenoma; and EPack, a disposable that is installed on the device before treatment to protect the patient's skin and optimize imag… Read more
Theraclion SA (TCLIF) - Total Assets
Latest total assets as of December 2024: $11.47 Million USD
Based on the latest financial reports, Theraclion SA (TCLIF) holds total assets worth $11.47 Million USD as of December 2024.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Theraclion SA - Total Assets Trend (2010–2024)
This chart illustrates how Theraclion SA’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Theraclion SA - Asset Composition Analysis
Current Asset Composition (December 2024)
Theraclion SA's total assets of $11.47 Million consist of 72.1% current assets and 27.9% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 36.4% |
| Accounts Receivable | $446.66K | 3.9% |
| Inventory | $2.11 Million | 18.4% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $1.13 Million | 9.9% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2010–2024)
This chart illustrates how Theraclion SA's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Theraclion SA's current assets represent 72.1% of total assets in 2024, an increase from 70.2% in 2010.
- Cash Position: Cash and equivalents constituted 36.4% of total assets in 2024, down from 53.0% in 2010.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 9.0% of total assets, a decrease from 28.0% in 2010.
- Asset Diversification: The largest asset category is inventory at 18.4% of total assets.
Theraclion SA Competitors by Total Assets
Key competitors of Theraclion SA based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Cheelcare Inc.
V:CHER
|
Canada | CA$4.27 Million |
|
FluroTech Ltd
OTCQB:FLURF
|
USA | $282.20K |
|
DRGEM Corporation
KQ:263690
|
Korea | ₩119.28 Billion |
|
Shanghai Kehua Bio-Engineering Co Ltd
SHE:002022
|
China | CN¥5.17 Billion |
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223
|
China | CN¥16.67 Billion |
|
Double Medical Technology Inc
SHE:002901
|
China | CN¥4.55 Billion |
|
Wuhan Easy Diagnosis Biomedicine Co Ltd Class A
SHE:002932
|
China | CN¥6.10 Billion |
|
Shinhung
KO:004080
|
Korea | ₩153.50 Billion |
Theraclion SA - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - Theraclion SA generates 0.07x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Theraclion SA is currently not profitable relative to its asset base.
Theraclion SA - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 2.21 | 3.54 | 1.86 |
| Quick Ratio | 1.64 | 2.87 | 1.45 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $4.53 Million | $ 11.56 Million | $ 3.25 Million |
Theraclion SA - Advanced Valuation Insights
This section examines the relationship between Theraclion SA's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.00 |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | -38.6% |
| Total Assets | $11.47 Million |
| Market Capitalization | $4.89K USD |
Valuation Analysis
Below Book Valuation: The market values Theraclion SA's assets below their book value (0.00 x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Theraclion SA's assets decreased by 38.6% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Theraclion SA (2010–2024)
The table below shows the annual total assets of Theraclion SA from 2010 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | $11.47 Million | -38.56% |
| 2023-12-31 | $18.66 Million | +33.85% |
| 2022-12-31 | $13.94 Million | +17.86% |
| 2021-12-31 | $11.83 Million | +12.18% |
| 2020-12-31 | $10.55 Million | +0.31% |
| 2019-12-31 | $10.51 Million | +9.91% |
| 2018-12-31 | $9.56 Million | -30.53% |
| 2017-12-31 | $13.77 Million | -6.43% |
| 2016-12-31 | $14.71 Million | +58.96% |
| 2015-12-31 | $9.26 Million | +11.74% |
| 2014-12-31 | $8.28 Million | +181.31% |
| 2013-12-31 | $2.94 Million | -7.87% |
| 2012-12-31 | $3.20 Million | +38.53% |
| 2011-12-31 | $2.31 Million | -40.99% |
| 2010-12-31 | $3.91 Million | -- |